Developmental Regression Analysis and Investigation of Genotype  Correlations in Individuals With Classic Rett Syndrome by Rose, Aubrey Lynn
University of South Carolina 
Scholar Commons 
Theses and Dissertations 
Spring 2021 
Developmental Regression Analysis and Investigation of 
Genotype Correlations in Individuals With Classic Rett Syndrome 
Aubrey Lynn Rose 
Follow this and additional works at: https://scholarcommons.sc.edu/etd 
 Part of the Genetics and Genomics Commons 
Recommended Citation 
Rose, A. L.(2021). Developmental Regression Analysis and Investigation of Genotype Correlations in 
Individuals With Classic Rett Syndrome. (Master's thesis). Retrieved from 
https://scholarcommons.sc.edu/etd/6213 
This Open Access Thesis is brought to you by Scholar Commons. It has been accepted for inclusion in Theses and 
Dissertations by an authorized administrator of Scholar Commons. For more information, please contact 
dillarda@mailbox.sc.edu. 
DEVELOPMENTAL REGRESSION ANALYSIS AND INVESTIGATION OF GENOTYPE 




Aubrey Lynn Rose 
 
Bachelor of Science 




Submitted in Partial Fulfillment of the Requirements 
For the Degree of Master of Science in  
Genetic Counseling 
School of Medicine  
University of South Carolina 
2021 
Accepted by: 
Debera Zvejnieks, Director of Thesis  
Hannah W. Moore, Reader 
Steven A. Skinner, Reader 








































© Copyright by Aubrey Lynn Rose, 2021  
All Rights Reserved  
 iii 
DEDICATION 
This research is dedicated to girls and women with Rett syndrome and their 
families. Your stories of perseverance, joy, and hope have inspired me to pursue this project 
and continue to inspire me as I strive to support families now and in the future. I am 
especially grateful to the families and patients enrolled in the Rett Syndrome Natural 
History Study. This project would not have been possible without this database, and I know 
that you have given your time in order to be included in this data. I hope that this research 
can help families with current diagnoses, and families who receive a diagnosis in the future. 
From the bottom of my heart, thank you.  
 iv 
ACKNOWLEDGEMENTS 
 I would not be where I am today without the support of my family and friends. 
First, thank you to my parents, who have supported and encouraged me throughout my 
journey to becoming a genetic counselor. I am also forever grateful for my classmates who 
have been by my side for the past two years. I couldn’t have done this without you and I’m 
so happy to say that I have made lifelong friends. I also want to thank my friends that were 
there for the late-night data analysis and last-minute phone calls. This project took a village 
and I’m glad I had support in so many forms. 
 I want to say a special thank you to Crystal Hill-Chapman for her assistance with 
statistics and data analysis. I appreciate you taking time to meet with me and to review my 
analysis and writing. I learned so much throughout this process and I cannot thank you 
enough for your guidance. 
 Finally, I want to thank my committee members and others at the University of 
South Carolina and Greenwood Genetic Center for their involvement in this project. I 
appreciate everyone who took time to review my project and offer suggestions and advice. 





Rett syndrome (RTT) is a neurodevelopmental disorder impacting 1 in 10,000 
females worldwide, making it one of the most common causes of complex disability in 
girls. RTT is caused by pathogenic variants in the MECP2 gene and is characterized by 
developmental regression, stereotypical hand movements, and an abnormal gait. Despite 
consistency in the presence of these core features, a wide range of features and varying 
severity can be observed in girls with RTT. Similarly, the particular type of MECP2 variant 
present also differs between patients. Previous studies have assessed correlations between 
genotype and phenotype in patients with RTT. While past research revealed some 
correlations, they were limited by small sample size and inconsistencies in data collection 
methods. This study uses data from the Rett Syndrome Natural History Study (RSNHS), a 
nationwide study that has been enrolling patients for the past 15 years. The analysis focuses 
on further characterizing developmental regression and features present in patients with 
RTT. The study also elucidates genotype-phenotype correlations in RTT, including 
patients with less common variants in MECP2. Analysis of these correlations focuses not 
only on overall severity but also on details of development and the presence of particular 
features. Results are consistent with previous studies of genotype-phenotype correlations 
in RTT and suggest that multiple features of RTT, including overall severity, regression 
onset, motor skills, and head circumference, differ significantly based on the type of 
MECP2 variant present. These correlations could provide important prognostic 
information for families with a new diagnosis of RTT.  
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1.1 Rett Syndrome 
Rett syndrome (RTT, MIM 312750) is a neurodevelopmental disorder that almost 
exclusively impacts girls. It is considered one of the most common causes of complex 
disability in females, with an estimated worldwide incidence of 1 in 10,000 females (Rett 
Syndrome, n.d.; Smeets et al., 2012). RTT was first described in 1966 by Dr. Andreas Rett, 
an Austrian pediatrician who recognized a pattern of symptoms in a number of his female 
patients (Rett, 1966). A short time later, Dr. Begnt Hagberg recognized similar symptoms 
in his patients in Sweden. In 1983, Dr. Hagberg published a report on the condition, naming 
it Rett’s syndrome (Hagberg et al., 1983). This spurred a rapid increase in research into the 
disorder, and in the 55 years since its first identification, understanding of RTT has 
progressed rapidly (Percy, 2014; Percy, 2016).  
RTT is characterized by developmental abnormalities and regression beginning 
between 6 and 18 months of age, following a period of seemingly normal development. In 
addition to regression, affected individuals experience both motor and cognitive symptoms. 
Patients diagnosed with classic RTT experience four main features: regression of fine 
motor skills, regression of communication skills, presence of hand stereotypies, and an 
abnormal or no gait. Other symptoms commonly observed in patients with RTT and 
atypical  RTT  are  known  as  minor  features.  These  characteristics  include  head  growth    
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deceleration, bruxism, abnormal breathing, sleep disruption, and abnormal muscle tone. 
Head growth deceleration can result in acquired microcephaly, in which head 
circumference may be within the normal range at birth but later measures more than two 
standard deviations (SD) below the mean. Despite having a known genetic etiology, RTT 
remains a clinical diagnosis. The presence of all four main criteria indicates a diagnosis of 
classic RTT. In contrast, the presence of a subset of major and minor features suggests a 
diagnosis of atypical, or variant, RTT (Percy et al., 2010). 
Classic RTT can be described in four main stages. Stage 1 is the “Early Onset 
Phase,” which starts around 6 to 18 months when patients exhibit subtle differences in 
development and may begin to show abnormal hand movements and hypotonia. Stage 2 is 
referred to as the “Rapid Destructive Phase,” usually observed between ages 1 and 4 years. 
During this time, developmental regression, hand stereotypies, and other Rett features 
become more apparent. Stage 3 is known as the “Plateau” or “Pseudo-Stationary Phase.” 
During this time, patients may see improvements in behavior, although motor problems 
and seizures can begin to occur more frequently. Some limited research has shown that 
certain skills that are initially lost during developmental regression can be relearned during 
this stage (Monteiro et al., 2014). The final stage of Rett syndrome is known as the “Late 
Motor Deterioration Phase” and is characterized by reduced mobility, scoliosis, muscle 
weakness, and more. It has been reported that during this phase, girls who previously could 
walk may lose that ability (D’Souza, n.d.; Dunn, 2001; Hagberg & Witt-Engerström, 1986; 
Monteiro et al., 2014; Rett Syndrome Fact Sheet | National Institute of Neurological 
Disorders and Stroke, n.d.). It is thought that most patients with RTT survive into at least 
their 20s, and there are some women that survive to their 40s or 50s. However, survival 
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rates are not well characterized at these later ages. Research suggests that respiratory 
infections, asphyxiation, respiratory failure, and seizures are the most common causes of 
death in patients with RTT (Anderson et al., 2014). 
RTT is most often caused by de novo variants in the MECP2 gene, meaning that 
variants are new in the patient and are not inherited from a parent. The MECP2 gene is 
found on the X-chromosome and encodes Methyl CpG Binding Protein 2 (MeCP2) (Amir 
et al., 1999). With advances in genetic technology, variants in other genes have also been 
recognized as causing certain features seen in RTT. This includes CDKL5, which is 
associated with epileptic encephalopathy (EEP2, MIM 300672), and FOXG1, which has 
been described as causing the congenital variant of RTT (MIM 613454). Variants in 
additional genes have also been observed in patients with overlapping features. However, 
pathogenic variants in MECP2 account for over 95% of classic RTT cases and 75% of 
atypical RTT cases (Vidal et al., 2019).  
MeCP2 functions as an epigenetic and transcriptional regulator and plays a role in 
the expression of many genes that are important for proper neuronal function. This protein 
consists of several major domains, including the N-terminal domain (NTD), methyl 
binding domain (MBD), intervening domain (ID), transcriptional repression domain 
(TRD), and C-terminal domains α and β (CTDα/CTDβ)  (Claveria-Gimeno et al., 2017). It 
is reported that MeCP2 has at least 40 binding partners, including transcriptional co-
repressors, transcriptional activators, chromatin remodelers, and splicing factors (Lyst & 
Bird, 2015). Research suggests that RTT-causing variants in MECP2 interfere with the 
protein’s ability to connect DNA to the NCoR-SMRT complex, which represses 
transcription when properly recruited (Tillotson et al., 2017). This is supported by the fact 
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that RTT-associated missense variants are seen primarily in the MBD and TRD, despite 
benign missense variants being observed throughout other regions of the MECP2 gene. 
The C-terminal domain is also a region in which pathogenic variants are known to cluster 
(Adkins & Georgel, 2011; Halbach et al., 2012; Lyst et al., 2013). While there is still much 
to understand about the mechanisms underlying MeCP2 function, this research provides 
essential clues towards disease pathology in RTT. It may also aid in the development of 
therapeutic approaches in the future.  
1.2 Advances in Early Diagnosis 
More than 99% of RTT cases result from de novo variants, many of which are of 
paternal origin. In rare cases, a pathogenic variant can be passed from a parent with gonadal 
mosaicism, more commonly from mothers with ovarian mosaicism (Zhang et al., 2012). 
Since the majority of cases are sporadic, family history rarely gives specific clues towards 
a genetic diagnosis. Rather than family history, diagnosis relies on the patient’s 
developmental history and features of the disease.  
In early accounts of Rett syndrome, development was described as being initially 
normal, with the first concerns appearing as developmental abnormalities and regression 
at 6-18 months of age (Amir et al., 1999). However, more recent research suggests that 
early development might not be as typical as it appears in individuals with RTT. Neul et 
al. (2014) reported that patients with classic RTT were less likely to develop particular 
skills as the skills became more advanced. For example, patients were more likely to 
acquire the ability to crawl but less likely to learn to walk. The same study also found that 
even among skills acquired, patients with classic RTT experienced delays in skill 
development compared to the timing expected for typically developing children.  
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Despite the recognition of early developmental abnormalities, this period still 
makes early diagnosis challenging. Some improvement in the age of diagnosis has been 
noted; since diagnostic criteria were first established in 1985, the average age of diagnosis 
has decreased from about six years old to about 2.5 years old. This may be due to improved 
developmental screening and increased testing of the MECP2 gene. However, the age of 
diagnosis has remained relatively steady since 2001, possibly due to the “wait-and-see” 
approach (Neul et al., 2014). Some literature calls for more rigorous screening during early 
development, in hopes of using these recently-understood early abnormalities to further 
improve the age of diagnosis (Cosentino et al., 2019).  
With recent advances in genetic testing, there may be another method to shift the 
age at which patients with Rett syndrome are diagnosed. In 2017, Natera, Inc. announced 
the launch of a new Non-Invasive Prenatal Test called “Vistara” (Natera, Inc. Announces 
Launch of Vistara Single-Gene Mutation NIPT, 2017). This test can detect 25 single-gene 
disorders, including Rett syndrome, and Natera states that the detection rate for pathogenic 
MECP2 variants is >78% (Vistara NIPT Single Gene Test, 2019). This test’s availability 
may lead to increased screening and detection of Rett syndrome in the prenatal period.  
With increased understanding of Rett syndrome and advances in genetic 
technology, early diagnosis is likely to become standard. This shift has many implications 
for patients and families, including earlier intervention, earlier enrollment into studies or 
clinical trials, and reduced psychosocial stress that may result from spending less time in 
the uncertain period between the onset of symptoms and diagnosis (Palacios-Ceña et al., 
2018; Tarquinio et al., 2015). It also allows for genetic counseling to occur at an earlier 
stage of the disease. Families of patients in this position will likely have questions 
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regarding what to expect in terms of their child’s development, including questions about 
regression and overall disease severity.  
1.3 Genetic and Phenotypic Variation 
There is significant genetic and phenotypic diversity among patients with 
pathogenic variants in MECP2 and a classic RTT diagnosis. Although classic RTT is only 
diagnosed in the presence of the same four core features, patients with this diagnosis vary 
greatly regarding when these features arise and how they present. For example, 
developmental regression shows significant variation among patients, differing in age of 
onset and specific skills lost. When evaluating the age of onset, past studies have observed 
regression beginning between the ages of 12 to 19 months (Einspieler & Marschik, 2019). 
Research also shows that the exact skills lost during regression differ between individuals. 
Skills lost during fine motor regression include holding a bottle, pincer grasp, and finger 
feeding. According to one study, these skills were lost in 32.2%, 40.8%, and 40.1% of 
patients, respectively (Tarquinio et al., 2015). Language regression included loss of 
babbling, single words with meaning, and phrases. The same study found that, respectively, 
37.9%, 58.7%, and 14.5% of patients lost these skills (Tarquinio et al., 2015). This 
illustrates how significantly regression varies among patients, even though it is a defining 
feature of classic RTT. Similarly, while all patients diagnosed with classic RTT experience 
stereotypical hand movements, the types of hand movements observed differ between 
patients. Individuals may experience hand wringing, mouthing, clapping/tapping, or other 
repetitive movements (Stallworth et al., 2019).  
Head growth deceleration and other features described as supportive diagnostic 
criteria can also be seen in up to 80% of RTT cases but are not observed in all patients 
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(Percy et al., 2010). Given this variation, it is well-established that overall severity differs 
between patients diagnosed with classic RTT. Several scales are available to evaluate 
severity; each scale rates aspects of phenotype to give patients a numerical severity score. 
On each scale, a higher score represents greater severity (Archer et al., 2007; Neul et al., 
2008). 
Similarly, there is also significant diversity in pathogenic MECP2 variants 
observed in patients with RTT. RettBASE, a variation database including major genes 
implicated in classic and atypical RTT, lists 925 unique MECP2 variants. While this 
includes both benign and pathogenic variants, 55.8% of these are described as either 
pathogenic or likely pathogenic. These variants range from relatively common, with up to 
420 cases reported, to very rare, with only one reported case (Christodoulou et al., 2003). 
RTT-causing variants include missense, nonsense, splice-site, and truncating variants. As 
previously discussed, pathogenic missense variants typically occur in either the MBD or 
the TRD, while truncating variants and large deletions can occur throughout the gene. C-
terminal variants are also known to be common disease-causing variants. In the cohort 
included in this study, there are more than 43 unique missense variants. This group also 
includes individuals with C-terminal deletions, splice variants, frameshift variants, large 
deletions, and early truncations in the MECP2 gene. 
1.4 Understanding Genotype-Phenotype Correlations 
With such a wide range of features, there is interest in understanding possible ways 
to better predict RTT phenotype. Some research has focused on determining whether the 
presence of some features in early development can predict the occurrence of others later 
in development. For example, recent research suggests that language skills developed early 
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in life may correlate with motor skills that are present later in development. In a recent 
publication, Saikusa et al. (2020) reported that walking ability over age ten was associated 
significantly with the acquisition of meaningful words, microcephaly, and crawling. 
Patients who acquired meaningful words, patients who learned to crawl, and patients 
without microcephaly were more likely to walk over age ten. Despite microcephaly being 
recognized even in early Rett syndrome reports, few studies have investigated this feature 
in great detail (Hagberg et al., 1983; Huppke et al., 2000). Some literature also suggests 
that microcephaly may be associated with an increased incidence of epilepsy in patients 
with Rett syndrome. However, this association is unclear and other research has reported 
no such correlation (Dolce et al., 2013). 
Another approach to predicting RTT features lies in focusing on the underlying 
genetic cause of the condition. Since RTT is an X-linked disorder, X-chromosome 
inactivation has been shown to have some correlation with overall severity in girls (Archer 
et al., 2007). Several studies have also evaluated the effects of pathogenic MECP2 variants 
on RTT features and on overall disease severity. These studies looked at specific 
pathogenic variants in MECP2, and some also grouped variants by their location in the 
MeCP2 protein. Past research has focused on variants in the MBD, TRD, and CTD when 
grouping variants since these are known “hotspots” for pathogenic variants in patients with 
RTT (Bebbington et al., 2008; Halbach et al., 2012).  
This previous research has revealed general phenotypic patterns that can be 
observed in the presence of some pathogenic MECP2 variants. Early research in this area 
showed significant differences in particular features when comparing missense and 
truncating variants (Monrós et al., 2001). Further research has revealed more trends, and 
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specific pathogenic MECP2 variants have been shown to correlate with overall severity 
and the age of onset of particular features. In assessing overall severity, reduced severity is 
observed among patients with the variants p.R133C, p.R294X, and p.R306C. Increased 
severity has been observed more frequently in patients with p.R168X, p.R270X, and 
p.R255X variants. Studies evaluating overall severity also reported that particular variants 
are associated with increased incidence of features such as the delayed onset of regression 
and hand stereotypies, reduced severity of oro-motor difficulties, preservation of hand 
skills, and head circumference (Bebbington et al., 2008; Cuddapah et al., 2014; Halbach et 
al., 2012; Neul et al., 2008). A study focusing on C-terminal deletions found that this 
variant group is associated with a mild to moderate disease severity. These variants were 
associated with a more severe phenotype than milder variants like p.R133C but showed 
reduced severity compared to more severe variants such as p.R270X and large deletions 
(Bebbington et al., 2010). 
Research focusing on genotype-phenotype relationships in RTT was 
overwhelmingly published before 2012. More recent publications sometimes include brief 
discussion of genotypic relationships but are confined to the most common pathogenic 
MECP2 variants (Neul et al., 2014). While existing data suggests some relationships exist 
between genotype and phenotype in patients with RTT, variable severity observed in these 
studies remains a concern, making it difficult to use these correlations to inform prognosis 
(Halbach et al., 2012). However, since these studies were published, information available 
in databases has grown, making it possible to study a broader range of existing MECP2 
variants in a larger cohort of patients. A number of these studies also used the InterRett 
database, which provides a valuable patient data source from an international cohort. 
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However, this data relies on clinicians and families to input available data, meaning that 
the database is not population-based and may increase inconsistencies in available data 
(Bebbington et al., 2008, 2010; InterRett, n.d.). This suggests the need for updated 
investigation of these relationships, particularly through analysis of a large cohort of 
individuals that has been followed over time. 
1.5 The Rett Syndrome Natural History Study 
The Rett Syndrome Natural History Study (RSNHS) provides a valuable database 
for investigating developmental regression and genotype-phenotype relationships in 
patients with classic RTT. The study has been registered with ClinicalTrials.gov: 
NCT00299312 since March 3, 2006, and NCT02738281 since April 14, 2016. There are 
14 sites involved in the study, located throughout the United States. The study includes 
data from individuals with classic RTT, atypical RTT, MECP2 Duplication, disorders that 
involve pathogenic variants in CDKL5 and FOXG1, and patients with other pathogenic 
MECP2 variants that do not meet the clinical criteria for RTT. Data were collected during 
clinic visits that were scheduled every six months until age six and annually after that point. 
After nearly 15 years of data collection, this study includes a substantial amount of 
longitudinal data on individuals with classic RTT, including the type of MECP2 variant, 
developmental milestones, and additional disease features. It also provides consistency in 
data collection, and includes regular assessments by trained physicians (“Natural History 
Study,” n.d.).  
1.6 The Value of Genotype-Phenotype Correlations in Genetic Counseling 
With the potential for earlier diagnosis, the value and need for prognostic data in 
RTT is increasing. This information could be beneficial given that the condition has such 
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a wide range of features and limited indications in early development. While research 
suggests that some relationships exist, there is little information regarding possible 
correlations between genotype and phenotype in Rett syndrome. Existing studies call for 
future investigation in this area, particularly in a cohort of patients that has been followed 
over time. The Rett Syndrome Natural History Study serves as a valuable source of this 
data, following many patients over an extended period. Though the use of this data, this 
study confirms previously observed relationships and expands on current knowledge of 
genotype-phenotype relationships in RTT with a focus on developmental regression. 
1.7 Objectives 
1. Assess characteristics of regression in patients with Rett syndrome, including age 
of onset, skills lost, and skills maintained or relearned. 
2. Determine whether correlations exist between specific pathogenic MECP2 variants 
and: features of Rett syndrome, regression onset, skills lost during regression, and 
overall disease severity. 
1.8 Hypothesis 
Specific pathogenic variants in the MECP2 gene will correlate with the presence of 
particular features of Rett syndrome and aspects of developmental regression including age 
of onset, skills learned, skills lost, and skills relearned. Specific MECP2 variants will also 
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2.1 Abstract 
Rett syndrome (RTT) is a neurodevelopmental disorder impacting 1 in 10,000 
females worldwide, making it one of the most common causes of complex disability in 
girls. RTT is caused by pathogenic variants in the MECP2 gene and is characterized by 
developmental regression, stereotypical hand movements, and an abnormal gait. Although 
these core features are observed in all patients, a wide range of features and varying severity 
can be observed in girls with classic RTT. Similarly, the particular type of MECP2 variant 
present also differs between patients. Some previous studies have assessed correlations 
between genotype and phenotype in patients with RTT. While past research revealed some 
correlations, they were limited by small sample size and inconsistencies in data collection 
methods. This study uses data from the Rett Syndrome Natural History Study (RSNHS), a 
nationwide study that has been enrolling patients for the past 15 years. The analysis focuses 
on characterizing developmental regression and features present in patients with RTT. The 
study also elucidates genotype-phenotype correlations in RTT, including patients with less 
common variants in MECP2. Analysis of these correlations focuses not only on overall 
severity but also on details of development and the presence of particular features. Results 
are consistent with previous analyses of genotype-phenotype correlations in RTT. They 
suggest that multiple features of RTT, including overall severity, regression onset, motor 
skills, and head circumference, differ significantly based on the type of MECP2 variant 
present. These correlations could provide important prognostic information for families 




Rett syndrome (RTT, MIM 312750) is a neurodevelopmental disorder that almost 
exclusively impacts girls. It is considered one of the most common causes of complex 
disability in females, with an estimated worldwide incidence of 1 in 10,000 females (Rett 
Syndrome, n.d.; Smeets et al., 2012). This disorder is characterized by developmental 
abnormalities and regression beginning between 6 and 18 months of age, following a 
period of seemingly normal development. In addition to regression, affected individuals 
experience both motor and cognitive symptoms. Patients diagnosed with classic RTT 
experience four main features: regression of fine motor skills, regression of communication 
skills, presence of hand stereotypies, and an abnormal or no gait. Other features often 
include head growth deceleration, bruxism, periodic breathing, sleep disruption, and 
abnormal muscle tone. Despite having a known genetic etiology, RTT remains a clinical 
diagnosis. The presence of all four main criteria indicates a diagnosis of classic RTT. In 
contrast, the presence of a subset of major and minor features suggests a diagnosis of 
atypical, or variant, RTT (Percy et al., 2010). 
RTT is often described in 4 main stages. Stage 1 is the “Early Onset Phase,” which 
starts around 6 to 18 months when patients exhibit subtle differences in development and 
may begin to show abnormal hand movements and hypotonia. Stage 2 is referred to as the 
“Rapid Destructive Phase,” usually observed between ages 1 and 4. During this time, 
developmental regression, hand stereotypies, and other Rett features become more 
apparent. Stage 3 is known as the “Plateau” or “Pseudo-Stationary Phase.” During this 
time, patients may see improvements in behavior, although motor problems and seizures 
can begin to occur more frequently. The final stage is known as the “Late Motor 
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Deterioration Phase,” and is characterized by reduced mobility, scoliosis, muscle 
weakness, and more. It has been reported that during this phase, girls who previously could 
walk may lose that ability (D’Souza, n.d.; Rett Syndrome Fact Sheet | National Institute of 
Neurological Disorders and Stroke, n.d.). 
RTT is most often caused by de novo variants in the MECP2 gene, which is found 
on the X-chromosome and encodes Methyl CpG Binding Protein 2 (MeCP2) (Amir et al., 
1999). Variants in additional genes have also been observed in patients with overlapping 
features. However, pathogenic variants in MECP2 account for over 95% of classic RTT 
cases and 75% of atypical RTT cases (Vidal et al., 2019). The MeCP2 protein functions as 
an epigenetic and transcriptional regulator and plays a role in the expression of several 
genes that are important for proper neuronal function. This protein consists of several major 
domains, including the N-terminal domain (NTD), methyl binding domain (MBD), 
intervening domain (ID), transcriptional repression domain (TRD), and C-terminal 
domains α and β (CTDα/CTDβ)  (Claveria-Gimeno et al., 2017). Research suggests that 
RTT-causing variants in MECP2 interfere with the protein’s ability to connect DNA to the 
NCoR-SMRT complex, which represses transcription when properly recruited (Tillotson 
et al., 2017). This is supported by the fact that RTT-associated missense variants are seen 
primarily in the MBD and TRD, despite benign missense variants being observed 
throughout other regions of the MECP2 gene. The C-terminal domain is also a region in 
which pathogenic variants are known to cluster (Adkins & Georgel, 2011; Halbach et al., 
2012; Lyst et al., 2013). 
There is significant genetic and phenotypic diversity among patients with 
pathogenic variants in MECP2 and a classic RTT diagnosis. Although classic RTT is only 
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diagnosed in the presence of the same four core features, patients with this diagnosis vary 
greatly regarding when these features arise and how they present. For example, 
developmental regression shows significant variation among patients, differing in age of 
onset and specific skills lost. Patients also differ in terms of which features may be present 
in addition to the core features of the disease. Head growth deceleration, bruxism, and other 
features described as supportive diagnostic criteria can be seen in up to 80% of RTT cases, 
but are not observed in all patients. Given this variation, it is well-established that overall 
severity differs between patients diagnosed with classic RTT. Several scales are available 
to evaluate severity. Each scale rates aspects of phenotype to give patients a numerical 
severity score. On each scale, a higher score represents greater severity (Archer et al., 2007; 
Neul et al., 2008; Percy et al., 2010). 
Similarly, there is also significant diversity in pathogenic MECP2 variants 
observed in patients with RTT. RettBASE, a variation database including major genes 
implicated in classic and atypical RTT, lists 925 unique MECP2 variants. While this 
includes both benign and pathogenic variants, 55.8% of these are described as either 
pathogenic or likely pathogenic. These variants range from relatively common, with up to 
420 cases reported, to very rare, with only one reported case (Christodoulou et al., 2003). 
RTT-causing variants include missense, nonsense, splice-site, and truncating variants. In 
this study cohort, there are more than 43 unique missense variants (Figure 2.1). This 
group also includes individuals with C-terminal deletions, splice variants, frameshift 











Figure 2.1. MeCP2 protein and amino acid variants observed in the study cohort. 
Functional domains of the MeCP2 protein are pictured. MBD = methyl binding domain,  
ID = intervening domain, TRD = transcriptional repression domain. 
 
 
With such a wide range of features, there is interest in understanding possible 
causes of phenotypic variation in RTT. Since RTT is an X-linked disorder, X-chromosome 
inactivation has been shown to have some correlation with overall severity in girls (Archer 
et al., 2007). Several studies have also evaluated the effects of pathogenic MECP2 variants 
on RTT features and overall disease severity (Bebbington et al., 2008; Halbach et al., 
2012). Specific pathogenic MECP2 variants have been shown to correlate with overall 
severity and the age of onset of particular features. In assessing overall severity, reduced 
severity is observed among patients with the variants p.R133C, p.R294X, and p.R306C. 
Increased severity has been observed more frequently in patients with p.R168X, p.R270X, 
and p.R255X variants. Studies evaluating overall severity also reported that particular 
variants are associated with increased incidence of features such as delayed onset of 












































regression and hand stereotypies, reduced severity of oro-motor difficulties, preservation 
of hand skills, and head circumference (Bebbington et al., 2008; Halbach et al., 2012; Neul 
et al., 2008). 
Research focusing on genotype-phenotype relationships in RTT was 
overwhelmingly published before 2012. More recent publications sometimes include a 
brief discussion of genotypic relationships but are confined to the most common 
pathogenic MECP2 variants (Neul et al., 2014). While existing data suggests some 
relationships exist between genotype and phenotype in patients with RTT, variable severity 
observed in these studies remains a concern, making it difficult to use these correlations to 
inform prognosis (Halbach et al., 2012).  
With the potential for earlier diagnosis, the value and need for prognostic data in 
RTT is increasing. This information could be beneficial given that the condition has such 
a wide range of features and limited indications in early development. While research 
suggests that some relationships exist, there is little information regarding possible 
correlations between genotype and phenotype in Rett syndrome. Existing studies call for 
future investigation in this area, particularly in a cohort of patients that has been followed 
over time. The Rett Syndrome Natural History Study (RSNHS) serves as a valuable source 
of this data, following many patients over an extended period. Through the use of this data, 
this study confirms previously observed relationships and expands on current knowledge 




There were 1,591 participants enrolled in the RSNHS when data was obtained in 
June 2020. Patients included in the analysis are female, have a diagnosis of classic Rett 
Syndrome, and have a pathogenic variant in MECP2. Males, patients with a diagnosis other 
than classic Rett Syndrome, patients with a MECP2 duplication, and patients with missing 
data were excluded from analysis (Figure 2.2).  
2.3.2 Research Methods 
This study is a retrospective review of data collected as part of the RSNHS. 
Relevant data were collected from available records, including detailed information about 
onset and presence of disease features and skills, head circumference, overall disease 
severity, specific MECP2 variant, and relevant demographic information (Appendix A). 
Responses and measurements were collected at multiple appointments throughout patients’ 
enrollment in the RSNHS.  
For analysis, patients were divided into groups based on MECP2 variant. Common 
groups used in the RSNHS included eight common missense and nonsense variants, C-
terminal truncations, early truncations, large deletions, pathogenic exon one variants, and 
pathogenic splice variants. A subset of the study participants had rare pathogenic missense 
variants and was not included in the groups listed above. These patients were grouped into 
three categories based on the location of the pathogenic missense variant in the MeCP2 
protein: C-terminal, MBD, and TRD (Figure 2.3). 
Some participants were initially grouped in study forms as having rare variants, but 


















































































Methyl Binding Domain Pathogenic Missense Variants  (MBD) 43
Transcription Repression Domain Pathogenic Missense Variants (TRD) 17
C-Terminal Pathogenic Missense Variants (C-Terminal) 17
C-Terminal Truncations (CTT) 129
Early Truncations (EarlyTrunc) 107
Large Deletions (LargeDel) 111
Pathogenic Exon 1 Variants (Exon1) 16






Figure 2.3. Categories of pathogenic variants used for analysis. 
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variants and one nonsense variant included in the early truncation group, one variant 
(p.Ala2Val) included in the group of pathogenic exon 1 variants, and one 3’ UTR variant 
that was grouped with pathogenic splice variants. 
Data was collected and organized using Microsoft Excel and exported to Statistical 
Package for Social Sciences (SPSS) version 25 for quantitative analysis. Microsoft Excel 
was used for descriptive statistics. Figures and tables were constructed using Microsoft 
Office Products and SPSS. 
2.3.3 Visit Dates 
The number of visits for each patient was determined using entries in both the 
Developmental History Log and the Clinical Severity Score Log. If the same patient had a 
different number of entries between these two forms, the larger number was used to 
determine the patient’s number of visits. The time between appointments varied, but visits 
were typically scheduled either every six months or once a year.  
The number of years that patients were seen as part of the RSNHS was calculated 
using the first recorded entry and the last recorded entry between the Developmental 
History and Clinical Severity Score Logs. The age at which patients were last seen was 
also calculated using each participant’s date of birth and the last recorded entry in the logs 
listed above. 
2.3.4 Clinical Severity 
Clinical severity score (CSS) is a quantitative scale used to determine the severity 
of overall clinical presentation in individuals with Rett syndrome. CSS was calculated 
using clinical observations made by experienced physicians involved in the RSNHS. The 
CSS is calculated using clinical features observed during an appointment and reported by 
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parents. Each feature is scored on a scale of 0-4 or 0-5, for a possible total of 53 points. A 
higher score corresponds with increased disease severity. For patients with multiple 
reported CSS scores, the mean CSS was calculated and used for analysis. 
2.3.5 Rett Features 
The protocol for the RSNHS was updated in 2016, and this update included changes 
to forms filled out during appointments and how data was collected for the study. Of data 
analyzed in this study, only changes to the Rett Features Log impacted how data was 
recorded and stored. To combine data for patients, responses to questions regarding the 
same information between the two forms were combined, and only features included in 
both questionnaires were analyzed. For patients who were seen multiple times throughout 
the study, responses were combined to represent whether a given skill was present at any 
visit. If a skill was present at any visit, the skill was recorded as present in the patient’s 
history regardless of the frequency at which the skill was observed. If a skill was never 
present, it was recorded as absent.  
2.3.6 Developmental History 
The presence of developmental skills and details of regression were categorized 
using the Developmental History Log. Responses were coded to represent skills that each 
participant never learned, learned+retained, learned+lost, and learned+lost+relearned. 
These categories were used for analysis. If a skill was marked as “lost” but had not been 
marked “gained”, the patient was included in the “learned+lost” group for this skill. 
Likewise, if a skill was marked as “relearned” but had not been marked “lost”, the patient 
was included in the “learned+lost+relearned” group for this skill. Ages that skills were 
learned, lost, or relearned were also included for some participants. In some cases, 
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participants were not recorded as having learned a skill, but had an age at which they 
learned the skill. In these cases, participants were recorded as having learned the given 
skill. This was also true for recording skills as lost or relearned.  
For analysis of skills assessed as part of developmental history, only patients who 
were seen as part of the RSNHS at age 12 or older were included in the analysis. This was 
done to help increase the chance that lost skills or relearned skills were not missed due to 
lack of follow-up. A total of 614 study participants were included in these analyses.  
Ages at which skills were learned, lost, and relearned were evaluated for ten skills: 
sat without support, cruised furniture while holding someone, walked independently, 
raking grasp, pincer grasp, finger fed, respond to familiar words, identified body parts, 
babbled, and words with meaning. These skills were chosen based on their importance in 
the clinical setting. Analysis of ages also included only participants seen at or after age 12. 
The additional analysis assessed skills lost after the age of 18. This analysis included only 
patients who were seen as part of the RSNHS after age 18 (n=369). 
Age of onset of regression was obtained using the clinical severity score form since 
this is one of the features used to score severity. Age of onset was recorded in one of six 
groups: <6 months, 6-12 months, 12-18 months, 18-30 months, >30 months, or unknown. 
Patients with an unknown age of onset of regression were excluded from the analysis.  
2.3.7 Head Circumference 
Head circumference (HC) was recorded in centimeters for patients at various ages. 
For this study, the HC z-score was calculated using estimated mean and SD values from 
the Nellhaus curve. The Nellhaus curve was selected since it is a widely-accepted curve 
used by neurologists to determine the HC percentile for patients up to age 18. Mean and 
 25 
SD values were estimated from the curve between ages 1 to 18 at 0.5-year intervals. Ages 
for each HC measurement were rounded to the nearest 0.5 years, and estimated mean and 
SD values at that age were used to calculate a z-score for each HC measurement. Z-scores 
for measurements taken above age 18 were predicted using estimated mean and SD at age 
18. The accuracy of this calculation was confirmed using a random sample of 18 
measurements which were plotted using software from Epic Systems. Calculated z-score 
values were within 0.5 SD of the mean when compared to values determined using Epic, 
with a mean difference in z-score of ±0.174 (SD 0.148, Range 0.491).  
Calculated z-scores were also used to characterize the frequency of acquired 
microcephaly among study participants. If any HC measurement taken during a 
participant’s time in the RSNHS was greater than two SD below the mean for the patient’s 
age at the time of the measurement, the patient was recorded as having microcephaly. If no 
HC measurements fell greater than two SD below the mean for each age that a 
measurement was recorded, a patient was recorded as not having microcephaly. 
The analysis only included patients who were seen as part of the RSNHS at age 12 
or older for analysis of correlations between microcephaly and skills lost during regression. 
Patients were included in the analysis if they had either learned+retained or learned+lost 
skills. Analysis was performed for the same ten skills for which ages were analyzed in 
Developmental History. 
2.3.8 Statistical Analysis  
 Descriptive statistics (frequencies and percentages) were calculated for categorical 
data. Binary logistic regression was used for variables with a binary output, including head 
circumference and data from the Rett Features Log. Differences in developmental skills 
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gained and/or lost, as reported in the Developmental History Log, were assessed using 
Pearson’s chi-square test for independence. Differences in age of onset of regression by 
MECP2 variant were also assessed using Pearson’s chi-square test for independence. 
Differences in head circumference and average clinical severity by MECP2 variant were 
assessed using linear regression. 
2.3.9 Human Studies Approval 
The University of South Carolina’s Institutional Review Board approved this study 
in June 2020. The RSNHS (ClinicalTrials.gov: NCT00299312, NCT02738281) has been 
enrolling patients since 2006. There are 14 participating sites: University of Alabama at 
Birmingham, UCSF Oakland Benioff Children’s Hospital, University of California San 
Diego, University of Colorado Denver, Rush University Medical Center, Children’s 
Hospital Boston, Gillete Children’s Specialty Healthcare, Washington University School 
of Medicine & St. Louis Children’s Hospital, Cincinnati Children’s Hospital Medical 
Center, Cleveland Clinic, Children’s Hospital of Philadelphia, Greenwood Genetic Center, 
Vanderbilt University, and Baylor College of Medicine. Every clinic obtained and 
maintained IRB approval throughout the study. Parental consent for study conduct and 
publication of results was obtained before entry into the study. 
2.4 Results 
2.4.1 Demographic Information 
The average age of participants at the time of the study was 19.64 years, and most 
(910/1,199; 75.90%) were followed as part of the RSNHS for a year or more. Participants 
were seen an average of 5.46 times (SD 3.81), and the number of visits ranged from 1 to 
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16. Patients who were seen more than once were followed for an average of 5.67 years (SD 
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Number of Years Followed
Number of Years Followed N %
Single Visit 218 18.18%
0-1 years 72 6.01%
1-3 years 241 20.1%
3-5 years 159 13.26%
5-7 years 160 13.34%
7-9 years 152 12.68%
9-11 years 81 6.76%






Of participants with available information regarding racial background, a majority 




Table 2.1. Demographic Information. 
 
 
Race N % 
Non-Hispanic White 874 73.14% 
Hispanic or Latino 173 14.48% 
Two or more races 55 4.60% 
Black 49 4.10% 
Asian 40 3.35% 
Native American/Alaskan Native 3 0.25% 
Native Hawaiian/Pacific Islander 1 0.08% 
Unknown 4 -- 
TOTAL 1199 100% 
 
 
2.4.2 Clinical Severity 
 Differences in average clinical severity between groups were assessed using a linear 
regression model. MECP2 variant group predicted average clinical severity, F(15)=13.619, 
p<0.001, and accounted for 13.7% of the variation in clinical severity (Adjusted R2=0.137). 
Average clinical severity scores and standard error of the mean (SEM) for each variant 
group are reported in Figure 2.5. 
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Figure 2.5. Average clinical severity score by MECP2 variant. 
Variant Grouping N Average CSS (SEM)
Exon 1 16 17.82  (1.43)
R133C 75 18.88  (0.71)
R306C 97 19.14  (0.63)
TRD 17 19.55 (1.89)
R294X 75 20.08  (0.68)
C-Terminal 17 20.29  (1.86)
CTT 129 20.78  (0.57)
MBD 43 22.92  (1.02)
T158M 127 23.94  (0.59)
R106W 44 24.02  (0.87)
Early Truncation 107 24.58  (0.63)
Splice Variants 16 25.40  (1.82)
Large Deletions 111 25.59  (0.73)
R255X 116 25.90  (0.62)
R270X 75 26.11  (0.83)





2.4.3 Rett Features  
 The most common feature observed among all participants was hand stereotypies, 
followed by constipation, drooling, bruxism, breath-holding, and cold/hot hands. Each of 
these features was observed in over 80% of participants. The least commonly observed 
features included gallbladder dysfunction, spitting, and hyperactivity, which were observed 
in less than 30% of participants. Frequencies of each Rett Feature are presented in Figure 
2.6 and Supplemental Table B.1.  
Logistic regression models were used to assess whether MECP2 variant predicted 
the frequency at which features were present in participants. The logistic regression model 
was statistically significant for the following skills: hyperventilation, aerophagia, spitting, 
bruxism, chewing problems, gastroesophageal reflux, constipation, sleep difficulty, 
waking at night, self-abusive behavior, and hyperactivity. A summary of logistic regression 
results for each Rett feature is presented in Table 2.2. Observed frequencies of selected 
skills by MECP2 variant are reported in Supplemental Figure B.1. 
2.4.4 Developmental History 
 Frequencies at which skills were never learned, learned, learned+lost, and 
learned+lost+relearned among all study participants are presented in Figure 2.7 and 
Supplemental Tables B.2-B.4. A chi-square test of independence was used to assess 
whether observed frequencies of patients that never learned, learned, learned+lost, and 
learned+lost+relearned skills differed significantly from expected values based on 
developmental skill. All expected cell frequencies were greater than five. There was a 
statistically significant association between developmental skill and frequencies learned, 

























































































































































Table 2.2. Logistic regression results – Rett features. Analyses with statistical 
significance (p<0.05) are reported in bold font. 
 
Rett Feature X2 df Cox & Snell R2 p-value 
Hand Stereotypies 10.911 15 0.009 0.759 
Hyperventilation 27.870 15 0.023 0.022 
Breath Holding 18.866 15 0.016 0.220 
Cold/Hot Hands 17.436 15 0.014 0.293 
Drooling 16.640 15 0.014 0.341 
Aerophagia 25.878 15 0.021 0.039 
Puffing Air 21.316 15 0.018 0.127 
Spitting 26.717 15 0.042 0.031 
Bruxism 35.954 15 0.030 0.002 
Chewing 
Problems 43.613 15 0.068 <0.001 
GE Reflux 31.916 15 0.026 0.007 
Constipation 36.772 15 0.030 0.001 
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Gall Bladder 
Dysfunction 23.645 15 0.020 0.071 
Sleep Difficulty 34.898 15 0.029 0.003 
Waking at Night 25.470 15 0.021 0.044 
Hard to Wake Up 20.404 15 0.017 0.157 
Day Sleeping 22.021 15 0.018 0.107 
Screaming Spells 19.522 15 0.031 0.191 
Self-Abusive 
Behavior 28.573 15 0.024 0.018 
Hyperactivity 38.449 15 0.060 0.001 
Low Activity 15.240 15 0.024 0.434 
Anxiety 24.214 15 0.038 0.062 











































































































































































































































































































































                              
 
 
Figure 2.7. Frequencies of developmental skills learned, lost, and relearned. 

































































































Chi-square tests of independence were used to assess whether observed frequencies 
of patients that never learned, learned, learned+lost, and learned+lost+relearned individual 
skills differed significantly from expected values based on MECP2 variant. Not all 
expected cell frequencies were greater than five. Observed values differed significantly 
from expected values for 34 of 51 skills. Results of all chi-square analyses are summarized 
in Tables 2.3 through 2.7. Observed frequencies of skills learned by MECP2 variant are 
reported for selected skills in Supplemental Figures B.2 through B.4. These figures show 
frequencies of patients who learned a skill compared to patients that never learned a skill. 
For presentation of this data, patients were included in calculation of these frequencies 
even if some later lost, or lost and relearned the skill. For selected graphs reporting 
frequencies of skills learned, learned+lost, and learned+lost+relearned, see Supplemental 
Figure B.5. 
The difference in regression onset by MECP2 variant was also assessed with a chi-
square test of independence. Thirty-five percent of cells had an expected count of less than 
five. There was a statistically significant association between variant group and age of 
onset of regression, X2(60) = 108.34, p<0.001. Graphs showing the age of onset of 
regression by MECP2 variant are shown in Figure 2.8. Observed values are reported in 
Supplemental Table B.5.  
Ages at which developmental skills were learned, lost, or relearned were assessed 
for ten skills: sat without support, cruised furniture while holding someone, walked 
independently, raking grasp, pincer grasp, finger fed, respond to familiar words, identified 
body parts, babbled, and words with meaning. Average ages learned and lost are shown in 
Figure 2.9. Average ages and SEM values are reported in Supplemental Table B.6.
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Table 2.3. Chi-square analysis of gross motor skills. Analyses with statistical 
significance (p<0.05) are reported in bold font. 
 
 
Developmental Skill Chi-Square Value df Asymptotic Significance 
Lift Head 61.771 45 0.049 
Rolled From Tummy 83.835 45 <0.001 
Sat with Support 43.335 45 0.543 
Sat without Support 68.960 45 0.012 
Come to Sit 93.317 45 <0.001 
Crawled 86.320 45 <0.001 
Stand while Hold 67.582 45 0.016 
Pulled to Stand 144.667 45 <0.001 
Cruised Furniture 
Holding Someone 106.701 45 <0.001 
Stood Independently 111.825 45 <0.001 
Walked 
Independently 151.955 45 <0.001 
Ran 10 Feet 73.006 45 0.005 
Climb up Stairs 
with Help 80.980 45 0.001 
Climb up Stairs 
without Help 103.168 45 <0.001 
Climb down Stairs 
with Help 90.389 45 <0.001 
Climb down stairs 
without Help 104.480 45 <0.001 
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Table 2.4. Chi-square analysis of fine motor skills. Analyses with statistical 
significance (p<0.05) are reported in bold font. 
 
 
Developmental Skill Chi-Square Value df Asymptotic Significance 
Held Bottle 
Unpropped 109.859 45 <0.001 
Reach for Toy 101.731 45 <0.001 
Raking Grasp 60.804 45 0.058 
Transfer Object One 
Hand to Other 96.875 45 <0.001 
Pincer Grasp 87.171 45 <0.001 
Finger Fed 90.144 45 <0.001 





Table 2.5. Chi-square analysis of receptive language skills. Analyses with statistical 
significance (p<0.05) are reported in bold font. 
 
 
Developmental Skill Chi-Square Value df Asymptotic Significance 
Soothe Adult Voice 31.473 45 0.937 
Respond To Sound 60.734 45 0.059 
Played Peek-a-Boo 62.460 45 0.043 
Respond Familiar 
Words 45.635 45 0.446 
Respond Own Name 38.003 45 0.761 
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Inhibit to ”No” or 
Different Tones 66.919 45 0.019 
Follow Command 
with Gesture 73.986 45 0.004 
Follow Command w/o 
Gesture 56.679 45 0.114 
Identified Body Parts 74.329 45 0.004 
Pointed to Color when 





Table 2.6. Chi-square analysis of expressive language skills. Analyses with statistical 
significance (p<0.05) are reported in bold font. 
 
 
Developmental Skill Chi-Square Value df Asymptotic Significance 
Social Smile 49.729 45 0.291 
Cooed 56.462 45 0.117 
Babbled 79.422 45 0.001 
Words with Meaning 52.362 45 0.210 
Spoken Phrases 86.377 45 <0.001 
Waved Bye 68.574 45 0.013 
Pointed When Want 109.926 45 <0.001 




Table 2.7. Chi-square analysis of personal-social/adaptive skills. Analyses with 
statistical significance (p<0.05) are reported in bold font. 
 
 
Developmental Skill Chi-Square Value df Asymptotic Significance 
Like Being Held 52.460 45 0.207 
Attention Loud Sound 56.505 45 0.117 
Fixed Follow Object 33.964 45 0.886 
Play Pat-a-Cake 73.930 45 0.004 
Desire Social 
Attention 59.748 45 0.069 
Imitate Peers 
Activities 87.266 45 <0.001 
Been Independent 61.215 45 0.054 
Take Drink w/o 
Assistance 77.455 45 0.002 
Spoon Fork with 
Assistance 73.230 45 0.005 
Spoon Fork without 








































































































































































































































Of 369 participants seen as part of the study after age 18, 29 had skills lost at age 
18 or later. A majority of participants that lost skills after age 18 (11, 37.93%) lost only 
one of 51 skills. The number of skills lost by participants in this period ranged from one to 
as many as 13 skills. Frequencies of patients who lost skills after age 18 are presented in 
Figure 2.10.  
Thirty of 51 skills had patients who were reported to have lost the skill after age 18. 
The skill most commonly lost during this period was walking independently (14 patients). 
Frequencies of skills lost after age 18 are reported in Table 2.8 
2.4.5 Head Circumference 
 A linear regression model was used to assess whether MECP2 variant accounted 
for any variation in the average HC z-score. This linear regression established that MECP2 
variant group could significantly predict average HC z-score, F(15)=4.758, p<0.001, and 
MECP2 variant accounted for 4.5% of the variation (Adjusted R2 = 0.045). The average 
HC z-score and SEM by MECP2 variant is presented in Figure 2.11. 
 A logistic regression model was used to assess whether MECP2 variant predicted 
the frequency at which microcephaly was observed in patients at any point in their 
enrollment in the Natural History Study. The logistic regression model was statistically 
significant, X2(15)=56.919, p<0.001. The model accounted for 4.7% of the variance (Cox 
& Snell R2=0.047) and correctly predicted 62.1% of cases. The frequency of acquired 
microcephaly by MECP2 variant group is presented in Figure 2.12. Frequency of acquired 
microcephaly is also included in Supplemental Figure B.1. 
A logistic regression model was also used to assess whether the average HC z-score 
























Figure 2.10. Regression after age 18. 
Number of Skills Lost After Age 18 Number of Patients
No Skills Lost After Age 18 340  (92.14%)
1 Skill Lost 11  (37.93%)
29  (7.86%)
2 Skills Lost 6  (20.69%)
3 Skills Lost 4  (13.79%)
4 Skills Lost 1  (3.45%)
5 Skills Lost 1  (3.45%)
7 Skills Lost 4  (13.79%)
9 Skills Lost 1  (3.45%)





                            Table 2.8. Frequencies of skills lost after age 18. 
 
Developmental Skill Number of Patients Who Lost After Age 18 
Lift Head 1 
Climb down Stairs 
Without Help 1 
Transfer Object One 
Hand to Other 1 
Inhibit to ”No” or 
Different Tones 1 
Cooed 1 
Waved Bye 1 
Pointed When Want 1 
Been Independent 1 
Spoon Fork without 
Assistance 1 
Sat with Support 2 
Ran 10 Feet 2 
Climb up Stairs Without 
Help 2 
Reach for Toy 2 
Babbled 2 
Take Drink w/o 
Assistance 2 
Cruised Furniture 
Holding Someone 3 
 51 
Climb up Stairs with 
Help 3 
Held Bottle Unpropped 3 
Social Smile 3 
Words with Meaning 3 
Sat without Support 4 
Come to Sit 4 
Climb Down Stairs with 
Help 4 
Raking Grasp 4 
Finger Fed 4 
Rolled From Tummy 5 
Stand while Hold 5 
Pulled to Stand 7 
Stood Independently 7 










































































































Figure 2.11. Average head circumference z-score by MECP2 variant. 
Variant Grouping N Average Head Circumference z-score (SEM)
Exon 1 16 -0.92  (0.28)
TRD 17 -1.39  (0.31)
R306C 97 -1.45  (0.12)
CTT 127 -1.53  (0.12)
C-Terminal 17 -1.58  (0.39)
R133C 75 -1.66  (0.16)
MBD 42 -1.84  (0.23)
R294X 75 -1.86  (0.15)
Early Truncation 107 -2.08  (0.13)
T158M 126 -2.09  (0.13)
R106W 43 -2.13  (0.22)
R255X 114 -2.13  (0.11)
R168X 130 -2.23  (0.11)
Large Deletions 110 -2.25  (0.14)
R270X 75 -2.37  (0.16)









Figure 2.12. Frequency of acquired microcephaly by MECP2 variant. 
A) Graph showing frequency (by percentage) of microcephaly in patients 
in each variant group. Dotted line shows the average frequency for all 































































Variant Grouping Present  (%) Absent  (%) TOTAL
Exon1 5  (31.3%) 11  (68.8%) 16
C-Terminal 6  (35.3%) 11  (64.7%) 17
TRD 6  (35.3%) 11  (64.7%) 17
R306C 43  (44.3%) 54  (55.7%) 97
R133C 36  (48.0%) 39  (52.0%) 75
R294X 36  (48.0%) 39  (52.0%) 75
CTT 64  (50.4%) 63  (49.6%) 127
MBD 23  (54.8%) 19  (45.2%) 42
T158M 79  (62.7%) 47  (37.3%) 126
R168X 86  (66.2%) 44  (33.8%) 130
earlytrunc 71  (66.4%) 36  (33.6%) 107
R255X 76  (66.7%) 38  (33.3%) 114
LargeDel 76  (69.1%) 34  (30.9%) 110
R106W 30  (69.8%) 13  (30.2%) 43
R270X 55  (73.3%) 20  (26.7%) 75
Splice 12  (75.0%) 4  (25.0%) 16






Developmental History Log. Skills analyzed include: sat without support, cruised furnature 
while holding someone, walked independently, raking grasp, pincer grasp, finger fed, 
respond to familiar words, identified body parts, babbled, and words with meaning. Of the 
ten skills assessed, the logistic regression model was significant for seven skills: sat without 
support, cruised furniture while holding someone, walked independently, raking grasp, 
pincer grasp, finger fed, and babbled. Logistic regression results are summarized in Table 
2.9. Selected graphs are shown in Supplemental Figure B.6. 
 
Table 2.9. Logistic regression analysis – head circumference and loss of 
developmental skills. Analyses with statistical significance (p<0.05) are reported in bold 
font. 
 
Developmental Skill X2 df Cox & Snell R2 p-value 
Sat Without Support 50.305 1 0.085 <0.001 
Cruised Furniture 
Holding Someone 58.721 1 0.113 <0.001 
Walked 
Independently 20.399 1 0.055 <0.001 
Raking Grasp 51.476 1 0.163 <0.001 
Pincer Grasp 41.566 1 0.088 <0.001 
Finger Fed 71.543 1 0.123 <0.001 
Respond Familiar 
Words 2.112 1 0.007 0.146 
Identified Body Parts 1.765 1 0.014 0.184 
Babbled 10.342 1 0.020 0.001 
Words With Meaning 0.178 1 0.000 0.673 
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2.5 Discussion  
2.5.1 Clinical Severity 
 This study aimed to evaluate to what extent differences in the type of pathogenic 
MECP2 variant contribute to variation in patients’ average clinical severity score. Results 
support the hypothesis that differences in MECP2 variant correlate significantly with 
overall disease severity. Previous investigations of genotype-phenotype correlations in Rett 
syndrome reported reduced severity in patients with MECP2 variants p.R133C, p.R294X, 
and p.R306C. In contrast, increased severity was observed in patients with p.R168X, 
p.R270X, and p.R255X variants (Bebbington et al., 2008; Halbach et al., 2012; Neul et al., 
2008). Patients with C-terminal truncations have been reported to have a more “moderate” 
phenotype, with severity falling between the more and less severe MECP2 variants 
(Bebbington et al., 2010).  
This study’s results were consistent with these previous observations, confirming 
correlations between MECP2 variant and average clinical severity score in a larger cohort 
of patients followed over time. Patients with exon 1, p.R133C, p.R306C, transcription 
repression domain, and p.R294X variants had the lowest average clinical severity scores, 
with average scores of 20.08 or less. Patients with p.R168X, p.R270X, or p.R255X variants 
had the highest average clinical severity scores, with average scores of 25.90 or above. C-
terminal truncations and C-terminal missense variants fell between these with average 
clinical severity scores of 20.78 and 20.29, respectively.  
 In addition to confirming previously observed correlations, this study investigated 
clinical severity in patients with less common MECP2 variants. Patients with large 
deletions, early truncations, and splice variants had higher average clinical severity scores, 
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with average scores between 24.58 and 25.59. Patients with pathogenic missense variants 
in the TRD had a milder phenotype, with a lower average clinical severity of 19.55. In 
contrast, patients with pathogenic missense variants in the MBD had a more moderate 
severity, with an average clinical severity score of 22.92. Previous studies investigating 
genotype-phenotype correlations have observed a higher clinical severity in patients with 
early truncations in the MECP2 gene, which is consistent with what was observed in this 
analysis (Monrós et al., 2001). However, previous research has been limited by study size 
and by the MECP2 variants present in their cohort, and this study is unique in its assessment 
of clinical severity in individuals with rare variants. 
2.5.2 Rett Features 
 This study also characterized the frequency of RTT features and assessed how 
occurence of RTT features differed between patients with different pathogenic MECP2 
variants. Of the 23 features assessed as part of this study, hand stereotypies, constipation, 
drooling, bruxism, and breath holding occurred most frequently. The least common 
features included hyperactivity, spitting, and gallbladder dysfunction. In a study from 2014 
using data from the InterRett Database, some of the most common features were breath 
holding (88%), scoliosis (86%), constipation (83%), hyperventilation (74%) and sleep 
disturbance (63%). Screaming spells were observed in 46% of patients, and gallbladder 
dysfunction was observed in only 5% (Anderson et al., 2014). Many of these frequencies 
are consistent with observations from this study. In particular, the current study identified 
constipation as one of the most common features (93%) and gallbladder dysfunction as one 
of the least common (8.6%). Frequencies of hyperventilation (74.5%), breath holding 
(88.6%), and sleep difficulties (59%) were all similar to observations from the previous 
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study. Compared to previous research, scoliosis was observed less frequently in this group 
(71.4%), and screaming spells were observed more frequently (60.4%). Importantly, this 
study expanded on the number of features characterized and benefits from the use of 
consistent questionnaires administered to all participants. 
 Results of logistic regression analysis support the hypothesis that type of MECP2 
variant correlates with the presence of particular RTT features. Specifically, a significant 
correlation was found for nearly half of the features assessed as part of this study. 
Hyperventilation, aerophagia, spitting, bruxism, chewing problems, constipation, 
gastroesophageal reflux, sleep difficulty, waking at night, self-abusive behavior, and 
hyperactivity were all found to differ significantly based on MECP2 variant. There is no 
previous research investigating association of MECP2 variant and presence of particular 
features in patients with RTT. One study did find a correlation with certain MECP2 variants 
and the severity of anxiety, suggesting that anxiety was more severe in patients with 
p.R133C variants compared to patients with p.T158M and p.R168X variants (Anderson et 
al., 2014). However, results of this study suggest that there are no significant differences 
in the frequency of anxiety with MECP2 variant, and severity of features was not assessed. 
2.5.3 Developmental History 
 Developmental regression was evaluated in several ways as part of this study. First, 
the study evaluated frequencies at which skills were learned, lost, or relearned. As reported 
in previous research, patients were less likely to learn more advanced skills as compared 
to skills that are less advanced (Neul et al., 2014). For example, the majority of participants 
in this study learned to sit independently, while only about 70% learned how to crawl. Just 
over half of patients learned to walk independently, and even fewer were ever able to run 
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10 feet. Acquisition of language skills followed similar trends. For example, while most 
patients learned to babble, fewer acquired meaningful words, and only about a quarter of 
patients ever used spoken phrases. It is unsurprising that results of this study are consistent 
with previous research in this area, given that data reported in 2014 by Neul et al. were 
collected as part of the same RSNHS. However, this study includes additional data that 
have been collected in the past 6 years since the data were initially published. 
 This study expanded on the understanding of developmental regression in RTT by 
identifying trends in skills that were more commonly lost by patients after being learned. 
Many fine motor skills, such as finger feeding, raking grasp, pincer grasp, reaching for a 
toy, and transferring objects between hands were learned by as many as 92% of patients, 
but were far more commonly lost compared to other motor skills. This is consistent with 
the understanding that patients with RTT typically learn these earlier motor skills but lose 
purposeful hand movements during the regression period (Percy, 2016). Similarly, many 
patients who learned to babble and use words with meaning also lost these skills during the 
regression period. This is reflective of the loss of communication skills that is included as 
one of the four major criteria for patients diagnosed with RTT (Percy et al., 2010).  
 Although evidence of patients with RTT relearning skills after regression has not 
previously been well categorized, each skill had a subset of patients who relearned the skill 
after losing it. Compared to motor skills, language and social/adaptive skills were more 
commonly relearned. Only one motor skill, reaching for a toy, was relearned in over 10% 
of participants, and even this skill was not relearned in the majority of the patients that lost 
it. In contrast, 6 language skills and 4 social skills were relearned by more than 10% of 
participants. A number of these skills, including responding to sounds, responding to one’s 
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name, and desiring social attention were relearned by the majority of patients that lost the 
skill.  
Additionally, this study assessed differences in whether skills were learned, lost, or 
relearned based on the type of MECP2 variant present in patients. Skills learned, lost, and 
relearned during development differ significantly based on pathogenic MECP2 variant. Of 
51 developmental skills assessed in this study, a majority showed statistically significant 
differences with the type of MECP2 variant. Most skills with significant findings were 
motor skills. Of 16 gross motor and seven fine motor skills assessed in this study, observed 
values were found to differ significantly from expected values for 15 skills and six skills, 
respectively. This is compared to significant differences in only about half of receptive 
language, expressive language, and personal-social adaptive skills. These findings indicate 
that, for patients with Rett syndrome, the specific MECP2 variant may have more of an 
impact on acquisition and loss of motor skills, and by comparison contributes less 
significantly to the variation observed in language and social skills.  
Even among skills used to assess language and social skills, many skills that 
showed significant differences based on MECP2 variant require particular motor abilities. 
For example, playing pat-a-cake is considered a personal-social skill in this study, but 
requires a level of motor coordination. This suggests that differences in motor skills may 
have confounded some measurements of language or social skills. This suggests the 
possibility that, when considering the effects of motor skills, MECP2 variant may have a 
smaller effect on certain language and social skills than what was determined in this study.  
This study also investigated variation in age of onset of regression with MECP2 
variant. For each variant, families reported regression onset occurring most commonly 
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between 12 and 30 months of age. However, observed values differed significantly from 
expected values when analyzed by MECP2 variant. Notably, several variants, particularly 
less severe variants such as Exon 1 variants, p.R133C, and transcription repression domain 
variants had a higher percentage of patients with regression onset later than 30 months 
(over 2.5 years old). Other variants, such as early truncations, large deletions, and more 
severe nonsense variants like p.R255X, p.R270X, and p.R168X had a number of patients 
with regression onset between 6 and 12 months, and even some patients with onset before 
six months. This is consistent with data from a previous study which reported significant 
differences in age of onset of regression with MECP2 variant (Bebbington et al., 2008). It 
also builds on these findings, supporting the hypothesis that age of onset of regression 
differs based on MECP2 variant in an analysis including patients with less common 
variants. 
Ages at which skills were learned, lost, and relearned were assessed for a subset of 
ten developmental skills. Skills such as sitting without support, finger feeding, babbling, 
responding to familiar words, and raking and pincer grasp were all learned on average 
before one year of age. Walking independently was learned at an average of 21 months. As 
has been previously reported, average ages that skills were learned by patients with RTT 
are somewhat delayed compared to expectations for typically-developing children as 
defined by the Centers for Disease Control and Prevention (CDC, 2020). For example, 
children are expected to babble beginning between four to six months of age. However, 
participants in this study learned to babble at an average age of nearly eight months old. 
Similarly, children are expected to learn how to cruise furniture at about 12 months and 
can typically walk by the age of 18 months old. In this study, participants learned these 
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skills at an average age of about 16 months and 21 months, respectively. These types of 
delays have been observed in previous research using data from the RSNHS (Neul et al., 
2014). 
Some of the earliest skills lost included responding to familiar words, identifying 
body parts, babbling, pincer grasp, and finger feeding. On average, these skills were lost 
by around age three years. On average, gross motor skills such as sitting, walking, and 
cruising furniture were lost later. Walking independently was lost the latest, with an 
average age of over nine years old. Walking independently was also the skill that patients 
relearned the latest, at an average age of about eight years old. However, ages that skills 
were relearned varied widely. For example, among patients who relearned how to walk 
independently, one participant lost the skill at about a year old and relearned how to walk 
at 15 months. Another participant who lost the ability to walk independently at age 30 years 
relearned the skill at 34 years old. 
These observations of developmental delays and age of onset of regression may 
provide some explanation for why age of diagnosis of RTT has remained consistent at 
about 2.5 years old. While there are delays observed in ages that skills are learned, delays 
are subtle and parents may be encouraged to “wait and see” whether their children learn 
skills before being referred to specialists (Neul et al., 2014). The age that skills are lost may 
also help to explain the overall later age of diagnosis for patients with RTT, since concerns 
may not be noted or acted upon until regression onset at around age 1.5 to three years.  
 It is widely acknowledged that patients with Rett syndrome experience a “Late 
Motor Deterioration Phase”, during which they lose additional skills, particularly motor 
skills (Hagberg & Witt-Engerström, 1986; Monteiro et al., 2014). This study aimed to 
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assess skills lost after age 18 years to more thoroughly characterize this later stage of 
developmental regression in patients with Rett syndrome. Of patients seen as part of the 
RSNHS after age 18, 29 patients (7.86%) lost skills in this later period. Most of these 
patients (37.93%) lost only one skill after age 18, but some patients lost as many as 13 
skills. The most common skill lost at later ages was walking independently, with 14 
patients losing this skill after age 18. Other skills commonly lost during this period were 
most often motor skills, including standing independently, pulling to stand, finger feeding, 
raking grasp, and climbing stairs. Fewer patients did lose skills such as cooing, babbling, 
and social smile. However, most language skills and social skills were not lost by any 
patients after the age of 18 years.  
Specific characterizations of this late stage of RTT have not been provided by 
previous studies. These results may indicate that fewer patients experience late regression 
than what was previously believed. However, it may also represent limitations in data 
collection and analysis. It may be that some skills are lost later than age 18, and patients 
included in analysis have not yet entered this disease phase. There were also limitations in 
the amount of data recorded regarding ages that skills were lost. It is possible that some 
patients who lost skills after age 18 are not represented in this data. 
2.5.4 Head Circumference 
 Although acquired microcephaly is a feature commonly associated with Rett 
syndrome, there have been limited previous studies assessing head circumference, head 
growth deceleration, and acquired microcephaly in a large cohort like that of the RSNHS. 
This study aimed to determine the frequency of microcephaly in this cohort and evaluated 
how head circumference varied with the type of MECP2 variant present in patients. 
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Previous research using data from the RSNHS has found that over 80% of patients 
experience head growth deceleration, but few studies have assessed how often this results 
in acquired microcephaly (Percy et al., 2010). One study found that only 46% of patients 
had head circumference measurements falling below the 3rd percentile (Pini et al., 2016). 
Results from this study are consistent with the idea that, while head growth deceleration 
has been observed in over 80% of patients with RTT, fewer patients develop acquired 
microcephaly. Only 59% of patients in this cohort had a head circumference measurement 
greater than 2 SD below the mean at any point during their enrollment in the RSNHS. 
 Additionally, results of this study support the hypothesis that differences in MECP2 
variant correlate with differences in average head circumference and frequency of 
microcephaly. This is consistent with results from a previous study that suggested the 
presence of significant differences in head growth between patients with a p.R294X variant 
and a p.R270X variant, where patients with a p.R294X variant were less likely to have a 
head circumference below the 3rd percentile in the first year of life (Halbach et al., 2012). 
This study found that only 48% of patients with a p.R294X variant had microcephaly occur 
during their enrollment in the study, compared to 73% of patients with a p.R270X variant. 
These differences were observed even when evaluating head circumference over a wider 
range of ages. Furthermore, this study was able to include other MECP2 variants in this 
analysis that have not been previously investigated.  
Some recent research has looked more closely at the impact of microcephaly on 
skills developed in patients with Rett syndrome. Most notably, a recent study suggests that 
walking ability over age ten is correlated with several early indicators, including 
microcephaly (Saikusa et al., 2020). Results of the Saikusa et al. (2020) study suggested 
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that patients with microcephaly were less likely to acquire the ability to walk by age 10. 
Similarly, this study assessed whether variation in head circumference correlated with 
whether selected developmental skills were lost or retained during the regression period. 
Results show that head circumference correlates with whether participants lost or retained 
certain skills, particularly motor skills. Of four language skills selected for assessment with 
head circumference, only babbling showed significance in the logistic regression model. 
However, 6 motor skills were found to have significant differences in frequency depending 
on head circumference z-score. For each of these seven skills, patients with a smaller head 
size were more likely to lose skills after initially learning them. This is consistent with 
observations reported by Saikusa et al. (2020) and furthers understanding of how presence 
of additional motor skills later in development may correlate with head circumference. 
Given these findings, head circumference could be another important predictor of future 
outcomes for patients with RTT.  
2.5.5 Limitations 
 While a diverse population was sampled for this study, the population distribution 
is not representative of the general US population, as it includes more Non-Hispanic White 
individuals and fewer Black individuals. Incidence of RTT is not known to differ by race, 
so differences in this study cohort likely represent an ascertainment bias.  White individuals 
in the population may be more likely to receive the proper diagnosis of RTT and enroll in 
this type of natural history study. Additionally, this study does not account for loss to 
follow-up, right-censoring, and the impact of age on features of RTT. When assessing skills 
learned, lost, and relearned, age was accounted for in that only patients above age 12 years 
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were included in analysis. However, differences in features and skills by age were not 
investigated. 
Although consistent surveys were used for collecting data in the RSNHS, there 
could still be challenges with interrater reliability given that there are 14 participating sites. 
As discussed in the methods section, adjustments were made in data analysis to correct for 
data recording errors that may have impacted results of this study. Several surveys also rely 
on parents’ ability to recall developmental milestones and early changes in development 
such as onset of regression. Previous studies have accounted for this by including 
participants in analysis only if they were seen at an earlier age when parents’ recall may be 
more reliable. However, this study did not use this method since one goal was to capture 
more information about loss and regain of skills later in life.  
 Finally, while this study benefited from a large number of participants, some 
analyses still had low sample sizes, particularly when participants were assigned to 
different MECP2 variant categories. Specifically, chi-square analyses used in this study for 
analysis of development and age of onset of regression may be limited since some expected 
values were lower than 5. Analysis of average ages that skills were lost and relearned may 
also be limited by the number of ages recorded. 
2.5.6 Future Directions 
 Areas for future research include investigating impacts of age on the presence of 
particular features and developmental skills. Studies could investigate more details of 
disease progression and may be able to evaluate differences in severity over time with 
particular MECP2 variants. Future research could also assess differences in severity of 
features based on MECP2 variant, particularly since previous studies have shown some 
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promise in this area but investigations have been limited. Additionally, given evidence of 
patients’ capacity to relearn skills after the regression period, it could be beneficial to 
pursue additional research into which therapies may be best suited for these individuals in 
order to maximize that capacity. Another area for future exploration may be determining 
families’ preferences regarding what information they want to receive at the time of 
diagnosis and at subsequent visits. This could be helpful in evaluating parents’ feelings 
regarding uncertainties in prognosis, and whether genotype-phenotype information would 
be considered important by families after an initial diagnosis given the variation that can 





This study aimed to assess genotype-phenotype correlations in patients with RTT 
and investigated these correlations with regards to overall disease severity, particular 
features of RTT, and attainment and/or loss of developmental skills. The results of this 
study are consistent with previous investigations into genotype-phenotype correlations in 
RTT but confirmed these correlations in a much larger cohort of patients compared to those 
that have been used before in this type of analysis. Additionally, it expanded this analysis 
to include patients with rare mutations and expanded some phenotypic investigations to 
include more specific features, particularly when looking at development. 
 For patients with a new diagnosis of RTT, these results may help answer questions 
regarding prognosis and provide families with more information about what to expect 
moving forward. As advancements in technology may allow for earlier diagnosis of RTT, 
this conversation will become increasingly common following diagnosis, particularly in a 
genetic counseling setting. Given the availability of Natera’s “Vistara” test for single-gene 
conditions via NIPT, genetic counselors may be more frequently asked to discuss these 
questions in the prenatal setting with no patient-specific clinical information other than 
MECP2 variant. 
 When discussing these types of correlations, it is important to consider differences 
present  even  among  patients  with  the  same  MECP2  variant.  Although  we  describe
 
 69 
significant differences between categories of MECP2 variant, there is still substantial 
variation within groups that could impact predictive power in a clinical setting. There are 
undoubtedly other factors that contribute to phenotypic variation in patients with RTT. For 
example, X-chromosome inactivation has been previously found to play a role in severity 
(Archer et al., 2007). It is also likely that social factors and even other genetic factors 
contribute to differences in phenotype among patients. Because of this variability, it is 
essential not to overstate the importance of MECP2 variant in determining prognosis for 
patients with RTT. However, it may be a tool that can be used as part of this conversation 
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INCLUSION CRITERIA AND SURVEY QUESTIONS 
Inclusion Criteria 
Diagnosis: Classic Rett Syndrome 
Gender: Female 




• A.1.e. Head circumference (cm) 
• A.1.f. Head circumference percentile 
 
Physician Initial History Form 
Diagnostic information 
• 6. Diagnosis 
• 8. Age at Diagnosis 
 
Genetic Testing Results 
• 2a. Common MECP2 Point Mutations 
• 2b. Common MECP2 Deletions 
• 2c. MECP2 Large Deletions 
• 2d. Other MECP2 Mutations not listed above 
 
Demographic and Birth History Form 
• 1. Child’s date of birth? 
• 2. Child’s gender? 
• 4. Child’s ethnicity? 
• 5. Child’s race? 
 
Clinical Severity Scale Form 3 
• Age of Onset of Regression 





Rett Features Log 





























Rett Feature % Present 




Breath Holding 88.63% 
Cold/Hot Hands 83.78% 
Waking at Night 78.60% 
Hyperventilation 74.50% 
Puffing Air 74.33% 
GE Reflux 71.99% 
Scoliosis 71.43% 
Aerophagia 70.65% 
Day Sleeping 69.48% 
Chewing Problems 68.38% 
Anxiety 64.85% 
Screaming Spells 60.35% 
Sleep Difficulty 59.03% 




Self-Abusive Behavior 57.44% 
Low Activity 46.23% 
Hard to Wake Up 35.37% 
Hyperactivity 20.87% 
Spitting 14.77% 






Figure B.1. Frequencies of Rett features by MECP2 variant. 






















































































Exon1 100.00% 93.75% 100.00% 75.00% 81.25% 68.75% 57.14% 31.25% 68.75% 68.75% 14.29% 0.00%
R133C 85.53% 84.21% 84.21% 57.89% 60.53% 61.84% 63.83% 48.00% 69.74% 59.21% 23.40% 19.15%
R306C 93.81% 91.75% 71.13% 79.38% 69.07% 62.89% 51.61% 44.33% 67.01% 58.76% 37.10% 16.13%
TRD 94.12% 88.24% 94.12% 70.59% 58.82% 47.06% 20.00% 35.29% 52.94% 82.35% 30.00% 50.00%
R294X 86.67% 85.33% 81.33% 80.00% 57.33% 68.00% 57.50% 48.00% 68.00% 70.67% 47.50% 20.00%
C-Terminal 100.00% 94.12% 76.47% 76.47% 64.71% 58.82% 61.54% 35.29% 47.06% 64.71% 30.77% 0.00%
CTT 86.82% 83.72% 73.64% 68.22% 65.89% 66.67% 66.13% 50.39% 55.04% 62.02% 19.35% 19.35%
MBD 95.35% 97.67% 72.09% 81.40% 74.42% 65.12% 59.09% 54.76% 55.81% 55.81% 22.73% 13.64%
T158M 97.66% 94.49% 76.38% 77.95% 75.59% 77.17% 64.52% 62.70% 51.18% 59.84% 12.90% 17.74%
R106W 97.73% 100.00% 88.64% 77.27% 81.82% 72.73% 76.00% 69.77% 77.27% 56.82% 12.00% 8.00%
EarlyTrunc 93.46% 96.26% 81.31% 76.64% 69.16% 66.36% 71.70% 66.36% 53.27% 47.66% 11.32% 18.87%
Splice 100.00% 87.50% 87.50% 87.50% 68.75% 68.75% 80.00% 75.00% 56.25% 68.75% 30.00% 30.00%
LargeDel 93.69% 92.79% 79.28% 72.07% 74.77% 72.97% 69.23% 69.09% 60.36% 54.05% 17.31% 9.62%
R255X 97.41% 92.24% 76.72% 71.55% 81.03% 80.17% 86.79% 66.67% 53.45% 50.00% 18.87% 11.32%
R270X 89.33% 93.33% 73.33% 66.67% 73.33% 74.67% 78.95% 73.33% 44.00% 42.67% 15.79% 5.26%
R168X 94.62% 95.38% 81.54% 83.08% 80.77% 77.69% 83.58% 66.15% 66.92% 60.77% 10.45% 8.96%
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Exon1 100.00% 100.00% 100.00% 100.00% 100.00% 90.00% 90.00% 100.00% 75.00% 90.00% 75.00% 75.00% 25.00% 50.00% 30.00%
R133C 100.00% 97.44% 100.00% 100.00% 97.44% 100.00% 89.74% 100.00% 92.00% 97.44% 76.00% 76.00% 54.17% 61.54% 51.28%
R306C 100.00% 100.00% 98.00% 100.00% 98.00% 98.00% 88.00% 96.00% 91.18% 88.00% 73.53% 61.76% 47.06% 44.00% 36.00%
TRD 100.00% 87.50% 87.50% 100.00% 87.50% 87.50% 62.50% 62.50% 75.00% 75.00% 50.00% 50.00% 75.00% 50.00% 50.00%
R294X 100.00% 100.00% 97.83% 91.67% 97.83% 97.83% 93.48% 91.30% 91.67% 93.48% 83.33% 79.17% 58.33% 58.70% 47.83%
C-Terminal 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 85.71% 71.43% 62.50% 62.50%
CTT 97.22% 100.00% 98.61% 91.67% 94.44% 94.44% 73.24% 83.33% 83.33% 79.17% 75.00% 66.67% 27.78% 38.89% 31.94%
MBD 87.50% 100.00% 100.00% 87.50% 76.47% 82.35% 64.71% 64.71% 62.50% 64.71% 62.50% 50.00% 50.00% 41.18% 23.53%
T158M 97.14% 96.97% 98.48% 91.43% 90.91% 90.91% 78.79% 80.30% 71.43% 71.21% 57.14% 40.00% 22.86% 25.76% 19.70%
R106W 100.00% 100.00% 95.45% 92.86% 73.91% 86.96% 65.22% 65.22% 57.14% 52.17% 42.86% 42.86% 7.14% 21.74% 17.39%
EarlyTrunc 96.00% 98.04% 90.20% 80.77% 78.43% 74.51% 64.71% 66.67% 50.00% 49.02% 48.15% 37.04% 18.52% 21.57% 15.69%
Splice 100.00% 88.89% 100.00% 71.43% 66.67% 55.56% 44.44% 22.22% 28.57% 33.33% 28.57% 28.57% 14.29% 11.11% 11.11%
LargeDel 100.00% 100.00% 98.18% 87.10% 85.45% 78.18% 67.27% 63.64% 56.67% 43.64% 38.71% 38.71% 22.58% 20.00% 18.18%
R255X 96.30% 94.74% 85.71% 70.37% 73.68% 73.68% 66.67% 57.89% 44.44% 45.61% 25.93% 18.52% 14.81% 12.28% 10.53%
R270X 95.00% 92.11% 92.11% 85.00% 81.58% 65.79% 71.05% 52.63% 70.00% 47.37% 55.00% 35.00% 19.05% 18.42% 10.53%





































































Exon1 100.00% 100.00% 90.00% 90.00% 70.00% 25.00%
R133C 97.44% 100.00% 94.87% 92.31% 87.18% 72.00%
R306C 100.00% 100.00% 98.00% 92.00% 80.00% 71.43%
TRD 87.50% 87.50% 100.00% 50.00% 37.50% 75.00%
R294X 100.00% 97.83% 93.48% 84.78% 82.61% 58.33%
C-Terminal 100.00% 100.00% 100.00% 100.00% 100.00% 57.14%
CTT 98.59% 98.59% 95.77% 87.32% 70.42% 57.14%
MBD 94.12% 88.24% 100.00% 76.47% 82.35% 75.00%
T158M 100.00% 90.91% 96.97% 75.76% 83.33% 45.71%
R106W 100.00% 91.30% 86.96% 73.91% 73.91% 50.00%
EarlyTrunc 94.12% 92.16% 84.31% 74.51% 74.51% 40.74%
Splice 100.00% 77.78% 88.89% 55.56% 66.67% 28.57%
LargeDel 100.00% 94.55% 87.27% 78.18% 65.45% 61.29%
R255X 96.49% 91.23% 80.70% 77.19% 61.40% 18.52%
R270X 97.37% 97.37% 84.21% 78.38% 68.42% 65.00%




















































































































































Exon1 100.00% 80.00% 100.00% 100.00% 75.00% 80.00% 30.00% 75.00% 60.00% 0.00% 75.00% 50.00% 100.00%
R133C 92.31% 79.49% 88.00% 84.00% 84.00% 87.18% 82.05% 72.00% 56.41% 48.00% 40.00% 43.59% 28.00%
R306C 100.00% 92.00% 77.14% 67.65% 80.00% 76.00% 66.00% 67.65% 52.00% 42.86% 40.00% 44.00% 28.57%
TRD 75.00% 87.50% 100.00% 75.00% 75.00% 75.00% 62.50% 50.00% 25.00% 50.00% 50.00% 12.50% 33.33%
R294X 86.96% 78.26% 66.67% 62.50% 79.17% 65.22% 60.87% 50.00% 43.48% 25.00% 50.00% 40.00% 16.67%
C-Terminal 100.00% 87.50% 71.43% 100.00% 100.00% 75.00% 87.50% 28.57% 75.00% 42.86% 57.14% 75.00% 14.29%
CTT 100.00% 83.10% 80.00% 67.65% 68.57% 66.20% 64.79% 41.67% 52.11% 34.29% 45.71% 43.06% 17.14%
MBD 100.00% 58.82% 87.50% 75.00% 87.50% 64.71% 64.71% 75.00% 35.29% 50.00% 62.50% 23.53% 37.50%
T158M 95.45% 68.18% 57.14% 57.14% 54.29% 63.64% 66.67% 29.41% 34.85% 44.12% 22.86% 24.24% 8.82%
R106W 100.00% 78.26% 28.57% 64.29% 57.14% 69.57% 69.57% 28.57% 21.74% 42.86% 21.43% 17.39% 7.14%
EarlyTrunc 94.12% 68.63% 70.37% 57.69% 65.38% 60.78% 47.06% 37.04% 25.49% 11.54% 22.22% 19.61% 23.08%
Splice 100.00% 77.78% 16.67% 85.71% 14.29% 66.67% 88.89% 57.14% 33.33% 42.86% 14.29% 0.00% 28.57%
LargeDel 92.73% 76.36% 58.06% 63.33% 54.84% 53.70% 52.73% 38.71% 25.45% 30.00% 22.58% 23.64% 16.13%
R255X 91.23% 59.65% 66.67% 51.85% 48.15% 47.37% 63.16% 38.46% 24.56% 22.22% 25.93% 19.30% 12.00%
R270X 83.78% 68.42% 65.00% 45.00% 70.00% 39.47% 45.95% 30.00% 29.73% 20.00% 35.00% 8.11% 15.00%





























































































































Cruised Furniture Holding Someone
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Table B.2. Motor skills – frequencies learned, lost, and relearned. 
 
 
Skill Never Learned Learned Learned+Lost Learned+Lost +Relearned 
Sat w/ Support 1.46% 85.37% 8.94% 4.23% 
Lift Head 1.79% 91.84% 4.08% 2.28% 
Reach For Toy 2.43% 42.45% 43.46% 11.66% 
Sat w/o Support 2.77% 78.12% 14.25% 4.86% 
Rolled Fr 
Tummy 3.87% 63.16% 28.43% 4.54% 
Finger Fed 7.80% 33.72% 52.43% 6.04% 
Raking Grasp 
Retrieve 10.11% 38.17% 46.82% 4.89% 
Held Bottle 
Unpropped 10.91% 34.98% 48.99% 5.12% 
Stand While 
Hold 13.96% 61.08% 22.00% 2.96% 
Come to Sit 17.03% 60.40% 19.30% 3.27% 
Cruised Furn 
Hold Someone 20.91% 58.35% 17.38% 3.36% 
Pincer Grasp 23.01% 18.22% 53.23% 5.54% 
Trans Obj Hand 
to Other 23.09% 22.33% 51.47% 3.11% 
Crawled 29.10% 52.90% 17.07% 0.93% 
Pulled to Stand 32.30% 39.01% 25.42% 3.27% 
 98 
Stood 
Independently 34.86% 46.81% 15.88% 2.45% 
Walked 
Independently 40.91% 42.50% 12.99% 3.60% 
Turn Pages 
Book 43.23% 14.68% 39.80% 2.28% 
Climb up Stairs 
w/ Help 45.92% 37.58% 14.38% 2.12% 
Climb Down 
Stairs w/ Help 55.79% 30.51% 12.07% 1.63% 
Ran 10 Feet 70.41% 16.91% 11.54% 1.14% 
Climb up Stairs 
w/o Help 74.50% 14.60% 9.82% 1.09% 
Climbed Down 



























Table B.3. Language skills – frequencies learned, lost, and relearned. 
 
 
Skill Never Learned Learned Learned+Lost Learned+Lost+Relearned 
Social Smile 0.50% 81.11% 3.61% 14.78% 
Respond To 
Sounds 2.61% 81.60% 3.26% 12.54% 
Respond Own 
Name 3.92% 78.79% 4.73% 12.56% 
Babbled 4.71% 42.52% 37.73% 15.04% 
Cooed 6.13% 56.26% 29.30% 8.31% 
Respond 
Familiar Words 8.50% 73.53% 8.50% 9.48% 
Quiet Soothe 
Adult Voice 10.26% 68.29% 6.90% 14.55% 
Words With 
Meaning 23.41% 8.22% 57.13% 11.24% 
Inhibit Diff 
Tones 28.97% 52.48% 9.82% 8.73% 




41.06% 30.19% 20.07% 8.68% 
Waved Bye 41.68% 6.89% 47.82% 3.61% 
Command 
Without Gesture 51.97% 25.61% 15.28% 7.14% 
Pointed Color 
Asked 53.59% 37.25% 6.05% 3.10% 
 100 
Identified Body 
Parts 57.61% 22.75% 16.86% 2.78% 
Pointed When 
Want 69.89% 9.25% 17.91% 2.94% 
Spoken Phrases 76.37% 2.86% 18.67% 2.10% 
Shared Stories 97.55% 0.82% 1.47% 0.16% 
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Skill Never Learned Learned Learned+Lost Learned+Lost+Relearned 
Like Being Held 4.04% 77.38% 5.21% 13.37% 
Fixed Follow 
Object 4.97% 66.39% 7.50% 21.15% 
Attention Loud 
Pr Sound 11.13% 71.52% 5.07% 12.27% 
Desire Social 
Atten 15.79% 68.59% 4.28% 11.35% 
Spoon Fork 
With Assist 32.57% 32.25% 30.78% 4.40% 
Take Drink w/o 
Assist 37.91% 23.69% 35.13% 3.27% 
Been 
Independent 64.85% 20.13% 12.71% 2.31% 
Play PatACake 71.26% 5.91% 22.33% 0.49% 
Spoon Fork w/o 
Assist 73.25% 7.01% 17.94% 1.79% 
Imitate Peers 
















30mos >30mos TOTAL 
Exon1 1 1 5 5 4 16 
R133C 0 2 16 47 10 75 
R306C 1 4 22 54 15 96 
TRD 0 0 8 6 3 17 
R294X 1 2 18 45 9 75 
C-Terminal 0 2 5 9 1 17 
CTT 2 11 40 58 18 129 
MBD 0 3 13 22 5 43 
T158M 0 9 53 59 6 127 
R106W 1 2 20 20 1 44 
Early 
Truncation 2 14 45 39 7 107 
Splice 0 0 6 9 1 16 
Large 
Deletion 2 8 41 52 8 111 
R255X 4 9 56 40 7 116 
R270X 1 9 28 33 4 75 
R168X 1 8 64 53 3 129 









Table B.6. Developmental skills – average ages learned, lost, and relearned.  












Sat Without Support 7.55  (0.26) 73.25  (5.73) 74.47  (13.98) 
Babbled 7.98  (0.42) 27.12  (1.84) 46.84  (6.15) 
Finger Fed 10.67  (0.28) 36.72  (2.25) 71.17  (14.02) 
Respond Familiar 
Words 10.80  (2.03) 23.62  (1.75) 59.00  (16.48) 
Raking Grasp 11.14  (1.25) 41.57  (5.25) 84.43  (37.73) 
Pincer Grasp 11.64  (0.58) 31.43  (1.49) 78.26  (13.14) 
Words with Meaning 12.40  (0.36) 27.99  (1.45) 49.53  (4.45) 
Cruised Furniture 
Holding Someone 16.17  (0.49) 67.28  (5.59) 84.32  (12.00) 
Walked Independently 21.02  (0.72) 110.92  (8.05) 96.55  (19.98) 





































































































Figure B.6. Developmental skills by head circumference. 
Points represent individual cases. Lines represent logistic 
curves. A measurement of 0.0 indicates patients who learned 
and lost a skill, and a measurement of 1.0 indicates patients 
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